Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France. Description of 62 novel mutations.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 16601827)

Published in Thromb Haemost on April 01, 2006

Authors

Christine Vinciguerra1, Christophe Zawadzki, Yesim Dargaud, Gilles Pernod, Claire Berger, Christophe Nougier, Claude Négrier

Author Affiliations

1: Laboratoire d'hémostase, Hopital Edouard Herriot, 69437 Lyon Cedex 03, France.

Articles by these authors

PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab (2007) 7.19

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood (2009) 2.64

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost (2012) 2.61

Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ Res (2011) 2.60

Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res (2013) 1.66

FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth (2005) 1.64

Activated partial thromboplastin time waveform analysis: a new tool to detect infection? Crit Care Med (2006) 1.59

Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis. J Clin Endocrinol Metab (2004) 1.58

Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer (2013) 1.54

Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem (2012) 1.54

Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis (2010) 1.52

Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J Thorac Cardiovasc Surg (2006) 1.46

Construction of a tube-shaped tracheal substitute using fascial flap-wrapped revascularized allogenic aorta. Eur J Cardiothorac Surg (2011) 1.44

Ultrafast relaxation of excited Dirac fermions in epitaxial graphene using optical differential transmission spectroscopy. Phys Rev Lett (2008) 1.43

Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia. Blood (2012) 1.43

Accuracy of complete compression ultrasound in ruling out suspected deep venous thrombosis in the ambulatory setting. A prospective cohort study. Thromb Haemost (2009) 1.43

Nanoscale tunable reduction of graphene oxide for graphene electronics. Science (2010) 1.41

Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury (2010) 1.36

Large area and structured epitaxial graphene produced by confinement controlled sublimation of silicon carbide. Proc Natl Acad Sci U S A (2011) 1.33

Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study. J Clin Oncol (2008) 1.32

Chemical modification of epitaxial graphene: spontaneous grafting of aryl groups. J Am Chem Soc (2009) 1.28

Room-temperature metastability of multilayer graphene oxide films. Nat Mater (2012) 1.24

A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood (2008) 1.16

Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer (2004) 1.12

Observation of resistively detected hole spin resonance and zero-field pseudo-spin splitting in epitaxial graphene. Nat Commun (2012) 1.08

Epitaxial-graphene/graphene-oxide junction: an essential step towards epitaxial graphene electronics. Phys Rev Lett (2008) 1.05

Spectroscopy of covalently functionalized graphene. Nano Lett (2010) 1.04

Spectroscopic measurement of interlayer screening in multilayer epitaxial graphene. Phys Rev Lett (2010) 1.00

Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature. Medicine (Baltimore) (2012) 0.99

A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet (2010) 0.98

Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat (2014) 0.97

Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica (2009) 0.95

Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages. Biochem Biophys Res Commun (2009) 0.93

Successive bleeding and thrombotic complications in a patient with afibrinogenemia: a case report. Thromb Res (2011) 0.93

Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood (2013) 0.93

Childhood cancer survival in France, 1990-1999. Eur J Cancer (2008) 0.92

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Engl J Med (2011) 0.92

Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion (2007) 0.90

Record maximum oscillation frequency in C-face epitaxial graphene transistors. Nano Lett (2013) 0.90

Quenching of the quantum Hall effect in multilayered epitaxial graphene: the role of undoped planes. Phys Rev Lett (2008) 0.89

Nonperturbative chemical modification of graphene for protein micropatterning. Langmuir (2010) 0.88

High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries. Haematologica (2006) 0.88

Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol (2013) 0.87

Effect of nitrophenyl functionalization on the magnetic properties of epitaxial graphene. Small (2011) 0.86

Anisotropy of excitation and relaxation of photogenerated charge carriers in graphene. Nano Lett (2014) 0.86

Laparoscopic radical nephrectomy for unilateral renal cancer in children. Surg Laparosc Endosc Percutan Tech (2009) 0.86

Coherent control of ballistic photocurrents in multilayer epitaxial graphene using quantum interference. Nano Lett (2010) 0.86

Should plasma homocysteine be used as a biomarker of venous thromboembolism? A case-control study. Clin Appl Thromb Hemost (2008) 0.85

Non-severe pulmonary embolism: prognostic CT findings. Eur J Radiol (2010) 0.85

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. Arch Cardiovasc Dis (2011) 0.84

Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagul Fibrinolysis (2003) 0.84

Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells (2005) 0.83

Weak antilocalization in epitaxial graphene: evidence for chiral electrons. Phys Rev Lett (2007) 0.83

Atomic structure of epitaxial graphene sidewall nanoribbons: flat graphene, miniribbons, and the confinement gap. Nano Lett (2014) 0.83

Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma. Microvasc Res (2011) 0.81

Two novel factor V null mutations associated with activated protein C resistance phenotype/genotype discrepancy. Br J Haematol (2003) 0.81

Functional mapping of factor VIII C2 domain. Thromb Haemost (2011) 0.80

[A pseudo aneurysmal subcutaneous tumor]. Ann Pathol (2003) 0.80

A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis. Thromb Haemost (2016) 0.80

[Fertility preservation in children and teenagers with cancer]. Bull Cancer (2013) 0.79

Identification of tissue factor in experimental aortic valve sclerosis. Cardiovasc Pathol (2008) 0.79

[Therapy education for patients receiving oral anti-coagulants vitamin K antagonists]. Presse Med (2009) 0.79

Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for other cancers. Thyroid (2013) 0.79

Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty: a potential role of tissue factor. Circulation (2003) 0.79

Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort. Hum Mutat (2015) 0.79

Self-reported and record-collected late effects in long-term survivors of childhood cancer: a population-based cohort study of the childhood cancer registry of the Rhône-Alpes region (ARCERRA). Pediatr Hematol Oncol (2013) 0.79

Increased MerTK expression in circulating innate immune cells of patients with septic shock. Intensive Care Med (2013) 0.78

Coagulation dynamics of a blood sample by multiple scattering analysis. J Biomed Opt (2011) 0.78

Thrombin-generating capacity in patients with von Willebrand's disease. Haematologica (2007) 0.78

Outcomes for inpatients with normal findings on whole-leg ultrasonography: a prospective study. Am J Med (2010) 0.78

New approaches to using FEIBA in the treatment of inhibitor patients. Semin Thromb Hemost (2006) 0.78

B-domain deleted factor VIII is aggregated and degraded through proteasomal and lysosomal pathways. Thromb Haemost (2005) 0.78

Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn). Thromb Haemost (2007) 0.78

Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia. Pediatr Blood Cancer (2006) 0.77

Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies. Drugs Aging (2009) 0.77

Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patient. Anesthesiology (2013) 0.77

Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology? Aging Clin Exp Res (2012) 0.77

Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning. Pediatr Hematol Oncol (2013) 0.77

Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits. Cardiovasc Pathol (2008) 0.77

Graft contraction phenomenon and tracheal stretching after tracheal replacement. Ann Thorac Surg (2011) 0.77

Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant? Thromb Haemost (2007) 0.76

Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria. J Physiol Biochem (2014) 0.76

Free leptin, carotid plaque phenotype and relevance to related symptomatology: insights from the OPAL-Lille carotid endarterectomy study. Int J Cardiol (2013) 0.76

Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications. Thromb Res (2012) 0.76

Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature. Thromb Haemost (2016) 0.76

Alpha cyano-4-hydroxy-3-methoxycinnamic acid inhibits proliferation and induces apoptosis in human breast cancer cells. PLoS One (2013) 0.76

Tracheal reconstruction with a composite graft: fascial flap-wrapped allogenic aorta with external cartilage-ring support. Interact Cardiovasc Thorac Surg (2012) 0.76

Functional mapping of the A2 domain from human factor VIII. Thromb Haemost (2012) 0.76

D-dimer level is not a prognostic biomarker specific of pulmonary embolism. Crit Care Med (2008) 0.75

Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women. A rebuttal. Thromb Res (2008) 0.75

Gene-gene interactions in myocardial infarction. Lancet (2006) 0.75

Letter by Marlu et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects". Circulation (2012) 0.75

Final height and body mass index after fractionated total body irradiation and allogeneic stem cell transplantation in childhood leukemia. Pediatr Hematol Oncol (2012) 0.75

Brief report: graduated compression stocking thromboprophylaxis for elderly inpatients: a propensity analysis. J Gen Intern Med (2006) 0.75

D-dimer and duration of anticoagulation. N Engl J Med (2007) 0.75